MyFinsight
Home
Blog
About
C4 Therapeutics, Inc. (CCCC)
C4 Therapeutics, Inc. (CCCC)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Subscribe for Financial Insights
Page 1
123
Page 1
Financial Ratios
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Free Cash flow
-1,611
-30,008
-22,156
-31,618
Return on Equity
-9.608
-10.886
-7.998
-20.756
Net Profit Margin
-357.732
-414.516
-186.302
-285.387
Debt to Asset Ratio
31.201
28.77
28.542
41.84
Cash Ratio
162.932
224.867
225.851
163.608
Quick Ratio
544.908
900.477
781.394
575.501
Current Ratio
544.908
900.477
781.394
575.501
Page 1
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Show more